These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37699048)

  • 1. Barriers and facilitators to ART adherence among ART non-adherence people living with HIV in Cameroon: A qualitative phenomenological study.
    Buh A; Deonandan R; Gomes J; Krentel A; Oladimeji O; Yaya S
    PLoS One; 2023; 18(9):e0291487. PubMed ID: 37699048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and factors associated with HIV treatment non-adherence among people living with HIV in three regions of Cameroon: A cross-sectional study.
    Buh A; Deonandan R; Gomes J; Krentel A; Oladimeji O; Yaya S
    PLoS One; 2023; 18(4):e0283991. PubMed ID: 37014900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caretakers' barriers to pediatric antiretroviral therapy adherence in Vietnam - A qualitative and quantitative study.
    Tran CT; Pham TH; Tran KT; Nguyen TKC; Larsson M
    Appl Nurs Res; 2017 Jun; 35():1-5. PubMed ID: 28532715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and facilitators to patients' adherence to antiretroviral treatment in Zambia: a qualitative study.
    Sanjobo N; Frich JC; Fretheim A
    SAHARA J; 2008 Sep; 5(3):136-43. PubMed ID: 18979047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability of a Mobile Phone Support Tool (Call for Life Uganda) for Promoting Adherence to Antiretroviral Therapy Among Young Adults in a Randomized Controlled Trial: Exploratory Qualitative Study.
    Twimukye A; Bwanika Naggirinya A; Parkes-Ratanshi R; Kasirye R; Kiragga A; Castelnuovo B; Wasswa J; Nabaggala MS; Katabira E; Lamorde M; King RL
    JMIR Mhealth Uhealth; 2021 Jun; 9(6):e17418. PubMed ID: 34121665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges faced by caregivers of virally non-suppressed children on the intensive adherence counselling program in Uganda: a qualitative study.
    Nasuuna E; Kigozi J; Muwanguzi PA; Babirye J; Kiwala L; Muganzi A; Sewankambo N; Nakanjako D
    BMC Health Serv Res; 2019 Mar; 19(1):150. PubMed ID: 30845951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan.
    Davis A; McCrimmon T; Dasgupta A; Gilbert L; Terlikbayeva A; Hunt T; Primbetova S; Wu E; Darisheva M; El-Bassel N
    Int J Drug Policy; 2018 Dec; 62():43-50. PubMed ID: 30359872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "The sky is the limit": adhering to antiretroviral therapy and HIV self-management from the perspectives of adolescents living with HIV and their adult caregivers.
    Denison JA; Banda H; Dennis AC; Packer C; Nyambe N; Stalter RM; Mwansa JK; Katayamoyo P; McCarraher DR
    J Int AIDS Soc; 2015; 18(1):19358. PubMed ID: 25591915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing adherence to antiretroviral therapy from the experience of people living with HIV and their healthcare providers in Sierra Leone: a qualitative study.
    Lahai M; Theobald S; Wurie HR; Lakoh S; Erah PO; Samai M; Raven J
    BMC Health Serv Res; 2022 Nov; 22(1):1327. PubMed ID: 36348488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What causes non-adherence among some individuals on long term antiretroviral therapy? Experiences of individuals with poor viral suppression in Uganda.
    Bukenya D; Mayanja BN; Nakamanya S; Muhumuza R; Seeley J
    AIDS Res Ther; 2019 Jan; 16(1):2. PubMed ID: 30665440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test but not treat: Community members' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa.
    Iwuji C; Chimukuche RS; Zuma T; Plazy M; Larmarange J; Orne-Gliemann J; Siedner M; Shahmanesh M; Seeley J
    PLoS One; 2020; 15(9):e0239513. PubMed ID: 32970730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda.
    Nabukeera-Barungi N; Elyanu P; Asire B; Katureebe C; Lukabwe I; Namusoke E; Musinguzi J; Atuyambe L; Tumwesigye N
    BMC Infect Dis; 2015 Nov; 15():520. PubMed ID: 26573923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "What if I got rejected by the girl? I would rather stop the pills": barriers and facilitators of adherence to antiretroviral therapy for emerging adults aged 18-29 living with HIV in Zimbabwe.
    Jopling R; Mutsvuke W; Fertig M; O'Cleirigh C; Mangezi W; Abas M
    AIDS Care; 2024 Jul; 36(sup1):168-178. PubMed ID: 38537178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative analysis of barriers and facilitators encountered by HIV patients in an ART adherence programme.
    Krummenacher I; Spencer B; Du Pasquier S; Bugnon O; Cavassini M; Schneider MP
    Int J Clin Pharm; 2014 Aug; 36(4):716-24. PubMed ID: 24913358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.
    Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G
    BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
    Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
    BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and facilitators for interventions to improve ART adherence in Sub-Saharan African countries: A systematic review and meta-analysis.
    Buh A; Deonandan R; Gomes J; Krentel A; Oladimeji O; Yaya S
    PLoS One; 2023; 18(11):e0295046. PubMed ID: 38032918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitators and barriers to antiretroviral therapy adherence among adolescents in Ghana.
    Ankrah DN; Koster ES; Mantel-Teeuwisse AK; Arhinful DK; Agyepong IA; Lartey M
    Patient Prefer Adherence; 2016; 10():329-37. PubMed ID: 27042024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living With HIV/AIDS in the Era of COVID-19: A Qualitative Study From Pakistan.
    Ahmed A; Dujaili JA; Jabeen M; Umair MM; Chuah LH; Hashmi FK; Awaisu A; Chaiyakunapruk N
    Front Pharmacol; 2021; 12():807446. PubMed ID: 35153763
    [No Abstract]   [Full Text] [Related]  

  • 20. Barriers and facilitators to viral load suppression among people living with HIV following intensive adherence counseling in Kampala, Uganda: A qualitative study.
    Izudi J; Cattamanchi A; Castelnuovo B; King R
    Soc Sci Med; 2024 Feb; 343():116595. PubMed ID: 38242033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.